degraded peptide FAQ

Inspect the lyophilised powder immediately. If it appears yellowed, clumped, or the vial interior shows condensation, request a replacement before reconstitution. Lyophilised peptides tolerate brief (under 6 hours) ambient temperature exposure during shipping, but prolonged warmth reduces long-term storage stability even if the powder looks intact. If the powder appears normal and the vial seal is intact, store it at −20°C and reconstitute within 3–6 months rather than the standard 12–24-month window. Document the shipment condition with photos and contact Real Peptides. Most suppliers replace temperature-compromised shipments as part of quality assurance protocols.

Discard the vial. Even 8–12 hours at room temperature (20–25°C) initiates peptide aggregation and oxidation that reduces antimicrobial potency by 20–40%, and visual inspection won't catch the loss. Reconstituted peptides lack the protective environment of lyophilisation. The aqueous solution accelerates hydrolysis of peptide bonds, especially at the N-terminus where the critical Met1 residue is located. There's no reliable way to "rescue" the peptide; refrigerating it after the fact only slows further degradation. If your protocol depends on precise dosing or quantifiable antimicrobial activity, starting with a compromised peptide invalidates the data.

Divide the reconstituted peptide into single-use aliquots immediately after mixing, then store aliquots at −80°C (not −20°C). Ultra-low temperature freezing (−80°C or below) minimizes ice crystal formation and can extend viability to 3–6 months, though each thaw still costs potency. Never refreeze a thawed aliquot. Thaw only what you'll use in a single experiment. Alternatively, reconstitute smaller volumes more frequently rather than mixing the entire vial at once. A 5mg vial can be split into two 2.5mg reconstitutions spaced weeks apart, keeping the unused powder at −20°C in lyophilised form where it remains stable.

Cloudiness after only 7 days suggests contamination, improper reconstitution technique, or an initial temperature excursion before you received the vial. Reconstituted LL-37 stored correctly at 2–8°C should remain clear for at least 21 days. Check the reconstitution process: did you use bacteriostatic water or sterile PBS? Was the vial stopper cleaned with 70% isopropanol before needle insertion? Did you allow the lyophilised powder to dissolve fully without vigorous shaking (which denatures peptides)? If protocol was correct, the peptide likely degraded during shipping or initial storage. Document the issue with photos and contact the supplier. This is not normal behavior for high-purity LL-37 and warrants batch investigation.

Discard it. Even if the peptide appears unchanged, 12–16 hours at ambient temperature (20–25°C) causes 20–35% potency loss through hydrolytic cleavage. The molecular damage precedes any visual marker. You cannot determine remaining activity without HPLC analysis. Research-grade experiments demand known, consistent peptide concentration. Using a compromised sample introduces uncontrolled variables that invalidate your data.

Stop using it. Cloudiness indicates protein aggregation. The VIP molecules have clumped together and lost receptor binding capability. This happens through hydrophobic interactions between partially unfolded peptides. The 2–8°C storage temperature slows but doesn't prevent this process. Bacteriostatic water extends microbial stability to 28 days, but it doesn't prevent chemical or physical peptide degradation. Most protocols recommend using reconstituted VIP within 14 days precisely because aggregation becomes measurable after that window.

Yellow discoloration signals oxidation of aromatic amino acids. Tyrosine or tryptophan. This happens through exposure to light, oxygen, or metal ion contaminants during storage or synthesis. While early-stage yellowing may still retain partial activity, the oxidation process is progressive and irreversible. If you're running quantitative assays where peptide concentration precision matters, discard the vial. For preliminary screening work where approximate activity is acceptable, you could use it with the understanding that potency is reduced by an unknown percentage.

Contact the supplier immediately and request a replacement with temperature logging data. Lyophilized DSIP can tolerate short-term ambient exposure (24–48 hours) without catastrophic degradation, but you cannot verify whether the shipment experienced temperature excursions above 25°C or prolonged warm storage. Reputable suppliers ship lyophilized peptides with cold packs or dry ice and include temperature indicators (irreversible color-change strips) that confirm the package remained within spec. If no temperature indicator was included or if it shows excursion, assume the peptide has partial degradation and request a credited replacement.

Discard it. Cloudiness indicates peptide aggregation or bacterial contamination, both of which render the solution unusable. Aggregated peptides cannot re-dissolve, and contaminated solutions introduce variables that compromise research validity. This pattern typically reflects one of two errors: (1) reconstitution with non-sterile water or a contaminated needle, or (2) storage in a refrigerator with temperature fluctuations (some household refrigerators cycle between 2–10°C). Use a dedicated laboratory refrigerator with stable temperature control and verify that bacteriostatic water is fresh (shelf life 28 days after opening).

Refrigerate it immediately and inspect for visual signs of degradation within 24 hours. If the solution is clear and colorless, it may still be viable. Peptides tolerate short-term ambient exposure better than prolonged heat. Contact the supplier to confirm their cold-chain shipping protocol and request a replacement if you suspect the vial spent more than 48 hours above 15°C. Most reputable peptide suppliers include temperature monitors in shipments for this reason.

Discard the vial. Do not attempt to salvage it by returning it to refrigeration. DSIP exposed to room temperature (20–25°C) for 8–12 hours undergoes measurable aggregation and peptide bond cleavage. Even if the solution appears clear, functional potency has declined by 20–40%, and microbial contamination risk increases exponentially in bacteriostatic water held above 8°C. The cost of the lost vial is negligible compared to the research time wasted using degraded peptide that produces unreliable results.

Discard it. Even a single 8-hour temperature excursion at room temperature (20–25°C) accelerates oxidation enough to compromise 30–50% of methionine residues. The solution may still look clear, but the lipotropic activity is degraded. We've seen researchers try to salvage these vials. The injection produces no metabolic effect, and they've wasted both the peptide and the injection cycle.

This suggests bacterial contamination or pH drift, not temperature failure. If you've been using the same vial for multiple draws without swabbing the rubber stopper with alcohol before each puncture, bacteria may have entered the solution. Alternatively, if the vial was stored near a freezer vent and partially froze, peptide precipitation can occur. Either way, discard the vial. Cloudiness is non-negotiable.

Cloudiness indicates peptide aggregation. Denatured molecules clumping together and precipitating out of solution. This is a hard stop: the peptide is no longer usable. Aggregation is typically caused by one of three things: temperature excursions (the fridge temperature spiked above 8°C), repeated exposure to light (peptides are light-sensitive and should be stored in amber vials or wrapped in foil), or contamination introduced during reconstitution. Even if only a portion of the peptide has aggregated, the remaining solution cannot be trusted for accurate dosing or consistent results. Replace the vial and audit your storage process. Verify fridge temperature with a data logger, use sterile technique when drawing doses, and minimize light exposure.

Discard it immediately. Do not attempt to use it. Yellowing or browning in lyophilized peptides indicates oxidation of amino acid residues (particularly methionine, cysteine, and tryptophan) or Maillard reaction products formed between amino groups and reducing sugars during improper storage. These chemical changes denature the peptide structure and eliminate biological activity. Oxidation is irreversible; no reconstitution method will restore potency. If the peptide was stored correctly at −20°C and still discolored, the failure occurred during manufacturing or shipping. Contact the supplier for a replacement.

Discard the vial and do not use it in any research protocol. An 8–12 hour exposure to room temperature (20–25°C) causes measurable hydrolysis of peptide bonds and significantly increases the risk of bacterial contamination, even in bacteriostatic water. While the solution may still appear clear, potency has dropped by an estimated 15–30%, and microbial growth may have begun. Using degraded peptides introduces uncontrolled variability into experimental results. The cost of replacing the vial is negligible compared to the cost of unreliable data. For labs working with P21 and other sensitive peptides, implementing a cold chain SOP with temperature logging prevents these losses entirely.

Discard the vial if it was out of freezer storage for more than 12 hours. Lyophilised peptides tolerate brief ambient exposure (up to 4–6 hours at 20–25°C) during shipping or handling, but 24 hours at room temperature initiates measurable hydrolysis even in powder form due to atmospheric moisture adsorption. The peptide may still dissolve normally and appear intact, but potency can drop 10–20% or more. If the powder shows any clumping, discoloration, or caking, degradation has already occurred. Reconstituting it won't reverse the damage.

Reconstituted Epithalon stored at 2–8°C begins losing measurable potency after 28 days even under ideal conditions. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which prevents bacterial growth but does not halt peptide degradation. By day 35–40, expect 15–25% potency reduction; by day 60, the peptide may be 40–60% degraded. If you have a vial that's been refrigerated for 5–6 weeks and still looks clear, it's not "safe". It's simply less potent than it was at day 14. For consistent research outcomes, adhere strictly to the 28-day reconstitution window and prepare smaller volumes if your protocol requires extended timelines.

Do not use it. Freezing reconstituted peptides causes ice crystal formation, which physically disrupts peptide structure through mechanical shear stress and concentration gradients during the freeze and thaw process. Even if the solution appears clear after thawing, aggregation and fragmentation have occurred at the molecular level. We've tested this scenario across multiple peptide classes. Freeze-thaw of reconstituted solutions consistently produces 30–50% loss of bioactivity as measured by receptor binding assays. Discard the vial and prepare a fresh reconstitution from lyophilised stock stored at −20°C.

You can thaw it once and use it immediately, but expect 10–20% potency loss and do not refreeze it. Freezing a reconstituted peptide causes ice crystal formation, which physically disrupts the peptide structure and promotes aggregation. After thawing, inspect the solution carefully. If you see any cloudiness, particulates, or phase separation (layering), discard it. If it appears clear, use the peptide within 24 hours and note in your research log that the sample underwent a freeze-thaw event, as this introduces a confounding variable. The best practice is to aliquot reconstituted peptides into single-use vials immediately after mixing, so each aliquot is thawed only once.